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1. Introduction   
There are many factors that can influence an individual’s sleep pattern and quantity and 
quality of sleep. These factors can be cultural, social, psychological, behavioural, patho-
physiological and environmental. Sleep patterns can also be influenced by society and by 
changes within society. In recent times we have seen the introduction of longer working 
hours, more shift-work and 24-7 availability of commodities. At the same time secular 
trends of curtailed duration of sleep to fewer hours per day across westernized populations 
(Akerstedt & Nilsson 2003) has led to increased reporting of fatigue, tiredness and excessive 
daytime sleepiness (Bliwise, 1996). It is of interest that whilst some studies indicate that 
women may have better sleep than men in general (Lindberg et al, 1997; Goel et al, 2005), 
they also report a larger difference in the estimated time of sleep that they believe they 
require and the actual sleep time they achieve than men. This might indicate that their sleep 
debt (amount of sleep deprivation) is higher in women than in men (Lindberg et al, 1997). 
There is now a wealth of evidence to support the epidemiological link between quantity of 
sleep (short and long duration) and quality of sleep (like difficulties in falling asleep or of 
maintaining sleep) and cardiovascular risk factors. These include hypertension (Cappuccio 
et al, 2007; Stranges et al, 2010), type-2 diabetes (Cappuccio et al, 2010a) and obesity 
(Cappuccio et al, 2008; Stranges et al, 2008; Cappuccio et al 2011a) as well as cardiovascular 
outcomes (Cappuccio et al, 2011b) and all-cause mortality (Ferrie et al, 2007; Cappuccio et al, 
2010b). Additionally, there may be important gender differences in sleep and associated 
health outcomes (Miller, 2009 et al; Cappuccio et al, 2007). The deleterious effects of sleep 
deprivation can be seen on a variety of systems within the body, with detectable changes in 
metabolic (Knutson, et al. 2007; Spiegel, et al. 2009), endocrine (Spiegel, et al. 1999; Taheri, et 
al. 2004) and immune pathways (Miller & Cappuccio 2007; Miller et al, 2009).  
The physiological and hormonal changes that occur in pregnancy increase the risk of 
developing Sleep Disordered Breathing (SDB). It has been estimated that 10-27% of pregnant 
women may suffer from habitual snoring (Pien & Schwab, 2004) and there is growing 
evidence to suggest that snoring and sleep apnoea during pregnancy are associated with an 
increased risk of gestational hypertension and pre-eclampsia.  SDB and short sleep duration 
in pregnant women may also be associated with the risk of gestational diabetes.  
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This chapter will examine the evidence that suggests that short sleep duration and poor 
quality are associated with adverse maternal and foetal outcomes. Furthermore, it will 
examine the potential mechanisms which may underlie these associations including 
activation of the sympathetic nervous system, oxidation and inflammation and mechanisms 
leading to the development of insulin resistance (Izci-Balserak & Pien, 2010). It will also 
consider the prevalence of sleep disorders in pregnancy. The diagnosis, management and 
treatment of sleep disorders in pregnancy will be discussed along with implications for 
public health policy, etc. 
2. Sleep and pregnancy  
Pregnancy is associated with many maternal physiological and psychological changes both of 
which may have an effect on sleep. In the first trimester, hormonal changes may disrupt sleep 
and in the third trimester the large baby and the anxiety regarding delivery may have 
associated effects on sleep. Likewise post-partum, a newborn may disrupt sleep patterns. The 
review by Lee in 1998 demonstrated that there was a paucity of studies, which addressed the 
alterations of sleep in pregnant women, moreover many of these studies lacked sufficient 
power to allow consistent interpretation and replication of the results (Lee, 1998). Since then a 
number of studies have now been conducted but more research is still required to establish 
whether for example, a woman’s pre-pregnancy sleep pattern can affect outcome and to 
determine whether there is any effect of parity on sleep related maternal and foetal outcomes. 
The changes in circadian rhythm of various hormones and the associated changes to sleep 
architecture that occur throughout pregnancy are discussed by Wolfson and Lee (2005) in ‘The 
Principles and Practice of Sleep Medicine’ (Kryger, Roth and Dement (Eds)). 
2.1 Sleep deprivation: Adverse sleep changes in pregnancy quantity and quality   
Due to the lack of good longitudinal studies there is still little information on what 
constitutes normal sleep quality and quantity both during pregnancy and in the period 
following delivery. In a recent study however Signal et al quantified the change and 
variability in sleep duration and quality across pregnancy and post-partum in 8 healthy 
nulliparous and 11 healthy multiparous women (Signal et al, 2007). The women wore an 
actigraph and completed a sleep diary for seven nights during the second trimester, one 
week prior to delivery, and at one and six weeks post-partum. They observed that compared 
to multiparous women, nulliparous women generally had less efficient sleep, spent more 
time in bed and had greater wake after sleep onset in the second trimester, and spent less 
time in bed and had fewer sleep episodes a day at one week post-partum. The largest 
change in sleep however occurred during the first week after delivery with the women 
obtaining 1.5h less sleep than during pregnancy. In a more recent and larger study sleep 
was assessed using the Pittsburgh Sleep Quality Index (PSQI) in 260 women during the 
second and third trimester of pregnancy (Naud et al, 2010). Of the 260 women, 192 (73.6%) 
had a term delivery without any adverse outcome. The investigators reported that there 
were no differences in sleep parameters between pregnancies with adverse outcome and 
without adverse outcome. The PSQI scores however indicted that sleep quality deteriorated 
from the second (5.26 +/- 3.16) to the third trimester (6.73 +/- 4.02; P < 0.01). This 
deterioration was displayed in five of seven sleep components (P < 0.01). Scores in the "poor 
sleeper" range were recorded by 36% of women in the second trimester and 56%, of women 
in the third (P < 0.01). "Poor sleep" in both trimesters was associated with low or high 
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weight gain, low annual family income, and single motherhood (P < 0.01). A weak but not 
significant effect of season on sleep scores was recorded: The mean PSQI scores were 6.06 
(+/-3.96) in winter, 5.21 (+/-3.21) in spring) 5.33 (+/-3.04) in summer and 5.53 (+/-2.41) in 
autumn); (P=0.076). In a similar study of 189 nulliparous women Facco et al demonstrated 
that compared with the baseline assessment (mean gestational age (13.8 (+/-3.8)) the mean 
sleep duration was significantly shorter at 30.0 (+/-2.2) weeks gestation (p<0.01). They also 
observed that in the third trimester the proportion of patients who reported frequent 
snoring (at least three nights per week) was significantly increased, and that there was an 
increase in those who met the diagnostic criteria for the recognised sleep disorder ‘restless 
leg syndrome’. Furthermore, poor sleep quality, as defined by a Pittsburgh Sleep Quality 
Index score greater than 5, became significantly more common as pregnancy progressed 
(Facco et al, 2010).  
In a separate study Wilson et al also found that sleep efficiency was decreased in late 
pregnancy and was associated with an increase in cortical arousals when compared to 
women in early pregnancy and non-pregnant women. Compared to a control group, they 
found that women in the third trimester of pregnancy had more awakenings and had had 
poorer sleep efficiency. They had less stage 4 sleep and more stage 1 sleep and spent less 
time in rapid eye movement (REM) sleep (Wilson et al, 2010).  
Sleep quality also decreases as a woman approaches labour (Evans et al, 1995) but whilst 
little is known of the effect of sleep disturbance on labour or delivery outcome it has been 
common practice to administer morphine sulphate to women in either early or non-
progressing latent phase labour to induce sleep. It has been observed that on awakening the 
contractions are more regular and active. 
2.2 Sleep disorders in pregnancy   
Sleep-Disordered breathing (SDB) is the term used to describe a group of disorders which 
are characterized by abnormalities of respiratory pattern (pauses in breathing) or the 
quantity of ventilation during sleep. A recent study evaluated the frequency of sleep 
disordered breathing in women with gestational hypertension compared to healthy women 
with uncomplicated pregnancies. They observed that women with gestational hypertension 
may have a significantly higher frequency of sleep disordered breathing than do healthy 
women with uncomplicated pregnancies of similar gestational age. The frequencies of sleep 
disordered breathing in the more obese gestational hypertension group and the healthy 
group were 53% and 12% (p<0.001) (Reid et al, 2011). 
Obstructive sleep apnoea (OSA) is the most common of these sleep disorders and is 
characterized by the complete or partial collapse of the pharyngeal airway during sleep. To 
resume ventilation, feedback mechanisms arouse the individual, which leads to sleep 
disruption. OSA is associated with an increased CVD risk. Although, men are twice as likely 
to develop OSA as women, the risk is increased in women if they are overweight. Moreover, 
data from recent studies indicates that snoring and OSA increase during pregnancy. The 
prevalence of OSA is very low in normotensive women low-risk pregnancies but is 
increased among normotensive pregnant women with high risk pregnancies and, in those 
with gestational hypertension (pregnancy-induced hypertension (PIH)/pre-eclampsia) 
during pregnancy, the prevalence is even higher.  
PIH is characterised by high blood pressure with a flat circadian rhythm and in particular 
does not have the normal nocturnal dip associated with sleep. Risk factors for PIH include 
first time pregnancy, long periods (>10years) between pregnancies, multiple pregnancies, 
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women younger than 20 or older than 35 or women who are overweight, have a history or 
hypertension or kidney disease or diabetes. Recent studies indicate that OSA per se is an 
independent risk factor for gestational hypertension/pre-eclampsia and may contribute to 
other poor obstetrical outcomes. Good blood pressure control in pregnancy is important. 
Continuous Positive Airway Pressure (CPAP), which is used to treat OSA, may also have 
beneficial effects on blood pressure (Champagne et al, 2010). It may therefore be very useful 
in patients with PIH as this condition is associated with both increased blood pressure and a 
significantly narrowed upper airways and limited airflow during sleep (Izci et al, 2003). 
Continuation of treatment for OSA following the pregnancy may also be required. 
Insomnia is a sleep disorder which is characterised by a difficulty in initiating or maintaining 
sleep in combination with adverse daytime consequences. The daytime effects may include 
excessive fatigue, impairment of performance or emotional changes. Data from self-reported 
questionnaires suggests that sleep complaints are more frequent in pregnancy and that sleep 
disturbances increases as the pregnancy progresses. In a recent study of 300 women (100 
women in each trimester of pregnancy) it was observed that there was a significant increase in 
insomnia in the 2nd trimester, excessive daytime sleepiness (EDS) was also increased in 
pregnancy and the rate for specific awakenings increased by 63% in the first trimester, by 80% 
in the second trimester and by 84% in the third trimester (p<0.001) (Lopes et al, 2004). 
Restless leg syndrome is a neurosensory sleep disorder which begins in the evening. The 
associated symptomatic leg movements can prevent a person from falling asleep and 
contribute to poor sleep quality. Pregnant women have at least two or three times higher 
risk of experiencing restless legs syndrome (RLS) than the general population and women 
affected by pre-existing RLS often complain of worsening symptoms during pregnancy. It is 
associated with iron deficiency anaemia. The women who are most at risk are those with 
low folate, ferritin or haemoglobin prior to conception. Data from the existing 
epidemiological studies suggests that the rates may be as high as 27% in the third trimester 
(Lee et al, 2001; Manconi et al, 2004). Whilst RLS is a reversible syndrome in pregnancy and 
is typically limited to the third trimester it has been associated with adverse pregnancy 
outcomes and therefore needs to be taken seriously. The standard medications for RLS that 
contain dopaminergics or opioids should be avoided but preventative measures to increase 
the amount of folate should be encouraged at the first prenatal visit. 
Complaints of heartburn increase during pregnancy and if these progress to severe 
nocturnal oesophageal reflux may also contribute to sleep disruption.  
2.3 Sleep disturbances and adverse maternal and foetal outcomes  
In Western societies adverse pregnancy outcomes have been on the increase and in the 
United States over 1 million pregnancies are associated with adverse outcomes including 
increased maternal and infant morbidity. The current known risk factors however are 
insufficient for early detection of at risk individuals and attention has focused on sleep as an 
emerging new risk factor (Okun et al, 2009). A recent prospective cohort study of low-risk 
pregnant women suggested that there may be no differences in sleep parameters between 
pregnancies with adverse outcome and without adverse outcome (Naud et al, 2010). Other 
studies however have indicated that sleep deprivation in pregnancy may be associated with 
adverse maternal outcomes including gestational hypertension, pre-eclampsia and diabetes 
and difficulties with labour and delivery, depression and adverse effects on the foetus. Data 
suggests that women who snore or suffer from obstructive sleep apnea during pregnancy 
are more likely to suffer from gestational hypertension and pre-eclampsia. Data is also 
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accumulating to suggest that both short sleep duration and sleep-disordered breathing may 
be associated with an increased risk of gestational diabetes (Izci-Balserak & Pien, 2010). A 
study of Taiwanese women compared sleep quality using the PSQI between 150 second-
trimester and 150 third-trimester pregnant women and 300 non-pregnant women. (Ko et al, 
2010). The study demonstrated that the prevalence of poor sleepers was increased in 
pregnant as compared to non-pregnant women and that sleep quality of pregnant women 
was related to stress and depression.  
There is evidence to suggest that sleep deprivation during pregnancy increases the risk of 
preterm delivery and postpartum depression, and that systematic inflammation may be an 
important underlying mechanism in the association (Okun et al, 2009; Okun, et al 2011a, 
Chang et al, Okun et al, 2011b). Approximately 14.5% of women will experience an episode 
of post partum major depression (PPMD) and 25% will experience a recurrent episode 
(Wisner et al, 2006). Women with PPMD are also more likely to experience impaired 
relationships with their infant (Gavin et al, 2005). In a recent study 56 pregnant women with 
past history of PPMD but with no evidence of depression in their current pregnancy, had 
blood samples collected at 8 times during the first 17 weeks postpartum. The PSQI was also 
administered. Recurrence of depression was measured by two consecutive 21-item scores of 
> 15 on the Hamilton Rating Scale for Depression (HRSD) and by clinical interview. The 
blood was analysed for estradiol, prolactin, cortisol and IL-6. The results indicated that in 
this study, self-reported poor sleep quality but not hormone or cytokine levels were 
associated with PPMD recurrence (Okun et al, 2011a).  
Fatigue and sleep disturbance in late pregnancy are important determinants of both labour 
duration and delivery type. A prospective observational study of 131 women in their ninth 
month of pregnancy demonstrated that those women who slept less than 6 hours per night, 
as determined by 48-hour wrist actigraphy, sleep logs and questionnaires, had had longer 
labours and were 4.5 times more likely to have caesarean deliveries. Labours were also 
longer and were 5.2 times more likely end in caesarians in those women who had poor 
quality sleep (Lee & Gay, 2004).  
Amongst pregnant women snoring is common and it may have adverse effects on the 
foetus. In particular, foetal hypoxia may occur leading to an increase in systemic 
inflammation and an elevation in the number of circulating nucleated red blood cells 
(nRBCs) with an associated decrease in foetal wellbeing (Tauman et al, 2011). A recent 
population-based case-control study investigated whether snoring, sleep position and other 
sleep practices in pregnant women were associated with risk of late still birth, i.e. >28 
weeks’ gestation)(Stacey et al, 2011). No relation was found between snoring or daytime 
sleepiness and risk of late stillbirth. However, women who slept on their back (O.R. 2.54, 
95% C.I. 1.04 to 6.18) or on their right side (1.74, 0.98 to 3.01) on the night preceding the 
stillbirth or interview were more likely to experience a late stillbirth compared with women 
who slept on their left side. In addition women who got up to go to the toilet once or less on 
the last night (2.28, 1.40 to 3.71) and those who regularly slept during the day in the 
previous month (2.04, 1.26 to 3.27) were also more likely to experience a late stillbirth than 
the respective control counterpart. Possible mechanisms for the effect of sleeping position 
are: inhibition of venous return by compression and ensuing reduction in uterine blood flow 
(Milson & Forssman, 1984; Jeffreys et al., 2006), reduction in foetal oxygen saturation 
(Carbonne et al., 1996), reduced pulsatility index of the foetal middle cerebral artery (a 
surrogate for foetal hypoxia)(Khatib et al., 2011). An alternative explanation of these 
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findings, however, could be of reverse causality, due to reduced foetal movement, one of the 
most common symptoms seen before stillbirth (Chappell & Smith, 2011). 
The altered circadian patterns that accompany shift work are known to disrupt reproductive 
function in women. Female shift workers have more menstrual cycle irregularities than non-
shift workers (Labyak et al, 2002) and some report more sleep disturbances. A link between 
adverse pregnancy outcomes and shift work has also been suggested (Kutson, 2003) 
although in a recent study no relationship was found between rotating shift work and 
adverse pregnancy outcomes but an increase in late abortions/still births was reported in 
women who were working fixed night shifts (Schlünssen et al, 2007). 
The intense physical and psychological changes which women undergo during pregnancy 
may be associated with increased stress and reduced quantity and quality of sleep. These 
effects may in turn affect the mother-infant relationship either through pregnancy-related 
hormonal changes, changes in inflammatory markers, maternal fatigue or postpartum 
depression (Pires et al, 2010; Okun et al, 2011a). 
2.4 Mechanisms  
Sleep disturbances may affect maternal and foetal morbidity and mortality through a 
number of potential mechanisms. For example, increased nocturia (due to decreased 
bladder capacity and increased overnight sodium excretion) disrupts sleep. Gastro-
oesophageal reflux also leads to awakening and disruption of sleep; first due to a relaxed 
lower oesophageal sphincter (progesterone working as a muscle relaxant); and then due to 
pressure on the stomach and reduced gastric emptying (Bourjeily & Rosene-Montella, 2009). 
Restless legs, leg cramps and increasing frequency of contractions all also contribute to 
disturbed sleep (Bourjeily & Rosene-Montella, 2009). Furthermore, sleep disordered 
breathing can be magnified or occur in pregnancy as a result of poor sleep and decreased 
functional reserve capacity, increased weight from gestation and pregnancy related 
nasopharyngeal oedema (Izci-Balserak, 2008; Pien & Schwab, 2004). 
Sleep is not a passive state but is an active process in which memory consolidation, tissue 
restoration, metabolic and haemostatic processes occur (Adam,1980; Alvarez & Ayas, 2004; 
Ancoli-Israel, 2006; Benca & Quintas, 1997 as cited in Okun, 2011). Sleep disturbances are 
known to have effects on oxidation, glucose metabolism and the sympathetic nervous 
system and there is strong evidence to support an association with cardiovascular outcomes 
(Cappuccio et al, 2011b). Furthermore, the association between sleep deprivation and 
hypertension has been shown to be stronger in women than in men (Cappuccio et al, 2007). 
Cardiovascular disease is relevant to many adverse pregnancy outcomes including pre-
eclampsia and intrauterine growth restriction (IUGR) both of which are also associated with 
a greater risk of developing cardiovascular disease in later life (Okun et al, 2009). 
Inflammatory processes have been shown to be important in the development of 
cardiovascular disease and emerging evidence has demonstrated an association between 
increased inflammation and medical morbidity, including various pregnancy complications. 
Some of the mechanisms by which sleep deprivation may lead to adverse maternal and 
foetal outcomes are discussed in more detail below. 
2.4.1 Oxidation and inflammation  
Increased oxidative stress, endothelial dysfunction and inflammation are important in the 
development of cardiovascular disease. In OSA, the associated sleep disordered breathing 
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leads to episodes of hypoxia and then normoxia. This in turn leads to oxidative stress and a 
subsequent increase in inflammation. There is strong evidence that during pregnancy 
inflammation and oxidative stress is increased (Okun et al, 2009). There is also evidence that 
inflammatory markers and reactive species are present in a higher proportion of pregnant 
women who report sleep disturbances than those who do not.  
Okun et al recently put forward a model for the possible role of sleep and inflammation in 
the pathogenesis of adverse pregnancy outcomes (Okun et al, 2009). They proposed that 
disturbed sleep has its major effects in the first 20 weeks of pregnancy. It is at this time that 
major physiological events occur, including the re-modelling of maternal blood vessels to 
the placenta so as to increase blood flow. This process is abnormal in pre-eclampsia and 
IUGR; in vitro studies indicate that this in part is due to excessive inflammation which 
inhibits trophoblastic invasion. It is postulated that is in non pregnant individuals disturbed 
sleep in pregnancy may contribute to this increased inflammatory state. Increased 
circulating cytokines through a positive feed forward process may in turn contribute to 
sleep disruption. In addition poor health behaviours including smoking, alcohol and obesity 
can also contribute to the increase in inflammation; thus having a profound effect on 
vascular re-modelling and hence leading to adverse pregnancy outcomes.  
Interleukin 6 (IL-6) is a significant pro-inflammatory and anti-inflammatory agent. It is also 
released in several disease states, from muscles during exercise, from adipose tissue and 
blood vessel walls. In sleep, there is an increase in the availability of soluble IL-6-receptors 
during the late nocturnal period which enhances IL-6 signalling and was thought to have a 
positive effect on memory consolidation. The administration of intranasal IL-6 in a study in 
2009 was shown to increase slow wave activity and the consolidation of only emotional 
memories during sleep in test subjects compared to a placebo (Benedict et al, 2009).  
IL-6 is also increased in pregnancy as early as mid-gestation in women who report poor 
sleep duration and efficiency, poor sleep duration and sleep disordered breathing (SDB) 
(Okun et al, 2007a). In complicated pregnancies involving foetal hypoxia, there is evidence 
of foetal erythropoiesis shown by increased levels of circulating nucleated red blood cells 
(nRBCs). Levels of IL-6 and erythropoietin (EPO) mediate the production of nRBCs and, 
interestingly, a study on pregnant women who reported snoring (assessed using a sleep 
questionnaire) found high circulating levels of IL-6 and EPO in the umbilical cord blood 
shortly after birth (Tauman et al, 2011). In women suffering from pre-eclampsia compared 
with pregnant controls, levels of IL-6 are also markedly raised (Bernardi et al, 2008, Sharma 
et al, 2007). In addition they are shown to be more fatigued and suffer more from snoring 
and nasal airflow limitation (Bachour et al, 2008). This suggests that IL-6 could be a marker 
for foetal well-being raised in response to poor/disturbed sleep. It is also important because 
IL-6 is involved in the pathogenesis of insulin resistance and type 2 diabetes and gestational 
diabetes mellitus (Mohamed-Ali et al, 1997; Wolf et al, 2004).  
Disordered sleep in the pregnant state has correlation with increased levels of IL-10 across 
all trimesters (Okun et al, 2007b). CRP is raised in both non-pregnant and pregnant states 
that report poor sleep. Studies on women with pre-eclampsia compared to normal control 
pregnancies offer differing results. One by Bernardi et al shows no change in IL-10 levels 
and others show decreased IL10 in pre-eclamptic women (Zusterzeel et al, 2001). This would 
suggest a non typical pattern of inflammation in these women as they do not have raised IL-
10 or IL-1┚ (Bernardi et al, 2008). However, a major drawback of these studies is the 
measurement of IL-10 only once after diagnosis. Recent studies have suggested time 
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dependent lipid peroxidation in pre-eclamptic patient which allows the use of plasma 8-
isoPGF (2-alpha) as a marker for oxidative stress between 24-32 weeks but not 34-37 weeks 
of gestation. In a separate study whilst short sleep duration and poor sleep efficiency in both 
mid and late pregnancy were associated with higher stimulated levels of IL-6 there were no 
relationships were observed for TNF-┙ (Okun et al, 2007a). 
Adiponectin has insulin sensitising and anti-inflammatory properties (Makino et al, 2006). 
Oxidative stress, TNF-┙ and IL-6 have been shown to reduce adiponectin, a hormone 
released by adipose tissue in people with SDB/OSA (Makino et al, 2006; Lain & Catalano, 
2007). Insulin resistance increases in normal pregnancy, but is also associated with short 
sleep duration and SDB (Punjabi et al, 2004). Some studies have shown an increased risk of 
GDM in pregnant women who have lower levels of adiponectin and high levels of CRP 
(Willaims et al, 2004; Wolf et al, 2003; Qiu et al, 2004). Other studies have shown that 
pregnant women with GDM have lower levels of adiponectin TNF-┙, IL-6 and IL-10 
compared with controls (Ategbo et al, 2006). 
One study has found that pregnant women with SDB have higher levels of 
malondialdehyde (MDA) than their non snoring controls. However this study found no 
comparable difference between any negative foetal outcomes after birth (Koken et al, 2007). 
Other studies conclude that SDB and the resulting hypoxia/re-oxygenation increase reactive 
oxygen species which can cause cellular damage (Jerath et al, 2009; Roberts & Hubel, 2004). 
This is hypothesised to contribute to pre-eclampsia and gestational diabetes in pregnant 
women (Roberts & Hubel, 2004). 
2.4.1.1 Inflammation and maternal and foetal outcomes 
Increased inflammation (higher levels of IL-6, TNF-┙ and CRP) is also associated with adverse 
pregnancy outcomes such as pre-eclampsia, Intra-Uterine Growth Retardation (IUGR) and 
preterm birth (Bartha et al, 2003, Romero et al, 2006 and Freeman et al, 2004). It is unclear if the 
increase in cytokines occurs as a result of increased stress or if sleep deprivation is a 
contributing factor. In a high proportion of these outcomes, studies have found a failure of re-
modelling of spiral arteries, a process necessary for adequate placental perfusion following 
trophoblast invasion (Arias et al 1993). TNF-┙ was shown to interfere with trophoblast 
invasion in experimental studies (Fluhr et al, 2007 and Salamonsen, et al 2007). 
Some studies have also linked the increase in inflammatory markers and maternal 
depression to pre term labour and babies with low birth weight. Groer & Morgan found that 
of the 200 women who were 4 – 6 weeks postpartum, those who were depressed, had 
significantly smaller babies and more negative life events. These women also had low levels 
of cortisol, suggesting an ineffective restrain on inflammation (Groer & Morgan, 2007). A 
study in Goa, India of 270 women also had similar results, and in addition positively 
correlated the severity of depression to the risk of low birth weight (Odds Ratio 2.5) (Patel & 
Prince, 2006).  
Studies in the field of psychoneuroimmunology have shown that mothers suffering from 
postnatal depression have much higher levels of inflammatory markers than their non 
depressed controls. These markers include CRP, IL-6, interleukin-1┚ (IL-1┚), TNF-┙ and 
IFN-┛ (Miller et al, 2005). In the last trimester of pregnancy, raised markers are adaptive and 
prevent infection. However at abnormally large levels they increase the risk of depression 
(Maes et al, 2000). It was also shown that these women had lower levels of cortisol; however 
in response to an acute stressor, they produced much higher levels of IL-6 and TNF-┙ 
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compared to the non-depressed controls. The authors from this study of 72 women 
concluded that they had "cortisol blunting" (Miller et al, 2005). 
 
Author Study 
Population 
Maternal Effects Foetal Effects Inflammatory 
marker 
Summary 
Tauman 
et al 
(2011) 
122 pregnant 
women 
recruited, of 
which 39% 
had SDB 
Sleep Disordered 
Breathing 
Increased 
Erythropoiesis 
IL-6, EPO, 
nRBCs 
In pregnant women 
who were habitual 
snorers, there was 
evidence of  
increased foetal 
erythropoiesis 
shown by increased 
umbilical cord 
levels of nRBCs, 
EPO and IL-6  
Bachour 
et al 2008 
15 pre-
eclamptic 
women and 
14 pregnant 
controls 
Increased time 
with nasal flow 
limitations, 
generalised 
oedema, 
increased fatigue 
and poorer 
pregnancy 
outcomes  
 
IL-6 , TNF-┙, 
and CRP 
Pre-eclamptic 
women presented 
with more snoring 
and had increased 
levels of IL-6 and 
TNF-┙ compared 
with controls. 
Overall their 
pregnancy 
outcomes were 
worse than 
controls.  
Bernardi 
et al 
(2008) 
35 pre-
eclamptic 
women and 
35 
normotensive 
women 
Pre-eclampsia  
IL-6, IL-10, 
IL-1┚ TNF-┙, 
protein 
carbonyls and 
plasma 
thiobarbituric 
acid 
 
IL-6, TNF-┙, 
protein carbonyls 
and plasma 
thiobarbituric acid 
were higher in pre-
eclamptic patients. 
IL-6 and carbonyls 
had significant 
correlation with 
blood pressure as 
well as each other. 
No increase in IL-
1┚ and IL-10 in 
pre-eclamptic 
patients. Effect of 
sleep disorders or 
complaints not 
investigated. 
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Author Study 
Population 
Maternal Effects Foetal Effects Inflammatory 
marker 
Summary 
Okun  
et al 
(2007a) 
19 Women in 
mid – late 
pregnancy 
Sleep complaints 
associated with 
increased 
inflammation. 
 IL-6 
Short sleep and 
poor sleep 
efficiency in mid to 
late pregnancy is 
associated with 
higher stimulated 
and circulating 
levels of IL-6. 
Women having 
sleep problems as 
early as mid 
gestation could 
also have increased 
inflammation. 
Okun & 
Coussons-
Read 
(2007b) 
 
35 pregnant 
women seen 
once a 
trimester. 43 
non-pregnant 
women seen 
once. 
Sleep complaints 
associated with 
increased 
inflammation. 
 
IL-10, CRP 
and TNF-┙ 
IL-10 and CRP 
were higher in 
pregnant women 
throughout the 
three trimesters. In 
women reporting 
sleep problems, 
TNF-┙ was 
significantly higher 
in pregnant 
women (across all 
trimesters) and 
CRP in non 
pregnant women. 
Koken et 
al (2007) 
40 snoring 
pregnant 
women and 
43 non 
snoring 
pregnant 
women 
Snoring  
Glutathione 
peroxidase 
(GSH-Px),  
Malondialdeh
yde (MDA) 
and 
Myeloperoxid
ase (MPO) 
Levels of GSH-Px 
were lower in the 
group that snored, 
and levels of MDA 
were much higher. 
Levels of MPO 
were comparable 
between the 
groups. There were 
no adverse 
outcomes 
associated with 
infants born to the 
mothers who 
snored. 
Table 1. Sleep disturbances, pregnancy and inflammation 
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The table summarises the studies to date on the effect of sleep disruption on markers of 
inflammation and the possible association with maternal and foetal outcomes.  
There is evidence to support the increase in inflammatory cytokines measured in amniotic 
fluids leads to preterm birth. A prospective cohort study of 681 women showed that 
depressed women were more than twice as likely to have preterm birth than their non 
depressed counterparts (9.7% vs. 4%; OR: 3.3). Prostaglandins in particular have a major role 
in uterine contractions and may be released early in response to increased pro-inflammatory 
cytokines in disturbed sleep. (Dayan et al, 2006). IL-6 and TNF-┙ have a role in ripening the 
cervix before birth; and in women who have preterm birth, these markers are raised in a 
study of 30 pregnant women. This suggests a link between inflammation and preterm birth, 
although in these women, stress was being assessed instead of sleep disturbances as a cause 
of raised cytokines. In a more recent study of 166 pregnant women, sleep was assessed by 
means of the PSQI. It was observed that for every one point increase in the PSQI score the 
odds of a preterm birth increased by 25% in early pregnancy and by 18% in late pregnancy 
(Okun et al, 2011b). Women who have SDB during pregnancy are also more likely to need 
an emergency caesarean (Leung et al, 2005). 
2.4.2 Activation of neuroendocrine pathways  
Activation of the sympathetic Nervous System (SNS) leads to the release of adrenal 
hormones (catecholamines), which can have an effect on sleep (Guggisberg, 2007). 
Furthermore, the production of catecholamines may stimulate the production of 
inflammatory cytokines. Inflammatory processes are modulated by numerous feedback and 
feed forward mechanisms. The Hypothalamic-pituitary-adrenal axis also regulates 
inflammatory processes via cortisol secretion, which is secreted in a diurnal manner 
following the sleep-wake cycle. Cortisol can suppress the production of pro-inflammatory 
cytokines and, as part of the negative feedback mechanism designed to prevent 
uncontrolled inflammation, pro-inflammatory cytokines stimulate the HPA axis to produce 
cortisol. However, as in the case of SDB and the resulting hypoxia, plasma cortisol is 
chronically raised (Meerlo et al, 2000). Prolonged cortisol secretion leads the glucocorticoid 
receptors becoming desensitised and results in a decrease in the protective effects of cortisol 
against inflammation (Sapolsky et al, 2000). Disrupted sleep can lead to mild stimulation of 
the HPA axis and increased inflammation, thus providing another mechanism whereby 
disrupted sleep in pregnancy may lead to dysregulation of normal homeostatic processes 
and potentially lead to adverse pregnancy outcomes (Okun et al, 2009). 
2.4.3 Insulin resistance  
Accumulating evidence suggests that both poor sleep quantity and quality are associated 
with impaired glucose tolerance and diabetes (Cappuccio et al, 2010a). Until recently little 
has been known about the effect of poor sleep during pregnancy on glucose tolerance and 
gestational diabetes. Qui et al interviewed a large cohort of 1,290 women during early 
pregnancy. They collected information regarding sleep duration and snoring during 
pregnancy. They obtained information on gestational diabetes mellitus (GDM) from the 
screening and test results in their medical records. They found that those women who slept 
4 hours or less had a greater risk of GDM than those sleeping 9 hours per night. 
Furthermore they observed that whilst the increased relative risk was 3.23 (95% CI 0.34-
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30.41) for lean women (<25 kg/m2) this was increased to 9.83 (95% CI 1.12-86.32) for 
overweight women (> or = 25 kg/m2). Snoring was also associated with a 1.86-fold 
increased risk of GDM and the risk of GDM was 6.9 xs higher in overweight than lean 
women (Qiu et al, 2010). These findings are consistent with data in non-pregnant women 
and warrant further investigation to determine the effect on pregnancy outcome.  
2.4.4 Passive smoking 
In Japan, two surveys were conducted to determine if passive smoking might have any effect 
on the sleep disturbances observed in pregnant women. 16,396 pregnant women were 
surveyed in 2002 and 19,386 in 2006. This is particularly important as 80% of passive 
environmental smoking comes from the spouse and in Japan there is a very high smoking rate 
amongst men (53%). The results indicated that passive smoking is independently associated 
with increased sleep disturbances during pregnancy. They observed that pregnant woman 
who were exposed to passive smoking were likely to suffer from difficulty in initiating sleep, 
short sleep, and snoring; those women who smoked suffered from the same disturbances and 
also reported early morning awakenings and excessive daytime sleepiness (Ohida et al, 2007). 
The authors suggest that some of the negative health outcomes observed in pregnant women 
may be mediated by the effect of active and passive smoking on sleep. 
2.5 Diagnosis and management of sleep disorders in pregnancy  
There are many different ways in which sleep data can be collected, the gold standard, 
however, is to measure sleep using polysomnography (PSG) as this provides an objective 
assessment of the sleep-wake cycle over the entire sleep period (Baker et al, 1999). Much of 
the data regarding sleep in pregnancy is limited to self-administered questionnaires and to 
diaries: very few recent studies have used PSG. However, it is recognised that undertaking 
multiple sleep studies at different time points during pregnancy is difficult. Despite this there 
is evidence to suggest that sleep disorders in pregnancy can in certain individuals have 
adverse outcomes for the mother or baby and therefore it would be useful to develop a 
screening tool that could be administered quickly by health professionals during routine 
pregnancy consultations. A simple and cost-effective alternative to PSG is to use actigraphy 
and sleep diaries. There are now many wrist-watch style actigraphs available. They are 
activated by movement and can differentiate when a person is awake or asleep, many also 
now have light monitors incorporated in them as well. They are useful in identifying night 
time awakenings and for determining their subsequent duration. When used in conjunction 
with self-recorded sleep diaries, actigraphs can help to establish a very detailed sleep pattern. 
Questionnaires administered to a bed partner can also help to establish a diagnosis of sleep 
disordered breathing. OSA is a common but often unrecognised condition in women of 
childbearing age. The likelihood is increased however in women with a past or current history 
of polycystic ovary syndrome, depression, hypertension, diabetes, hypothyroidism, metabolic 
syndrome, obesity (Champagne et al, 2010). The diagnostic test of choice would be a PSG, and 
referral to a sleep specialist to confirm and treat primary sleep disorders may be required. 
Further research is also required to establish if the management thresholds for treatment of 
OSA in non-pregnant women are applicable to pregnant women. 
Pharmacological treatment of sleep disorders in pregnancy needs to be viewed with caution, 
given the potential for harm to the foetus. Similar caution needs to extend to women who 
are breastfeeding. 
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2.6 Implications for public health  
In the general population sleep duration has been declining. Women now occupy an 
increasingly prominent position in the workplace but often they do so without any 
reduction in their home responsibilities. Consequently sleep needs are often of low priority. 
Preterm birth is a major public health priority and is a common adverse outcome in 
pregnancy. Sleep quantity and quality are not only important determinants of maternal and 
foetal health but are also important for general health and need to be particularly addressed 
in the post-partum period where sleep disruption is likely to be very common. There is also 
some evidence to suggest that the effects of sleep deprivation may be greater in women than 
in men. Despite this, the majority of studies undertaken are in men and there is now a clear 
need for more, large, multicentre, prospective studies to be performed in women.  
There is also a paucity of studies evaluating sleep disturbances in the post-partum period 
and research is required to look at the effects of sleep deprivation on both maternal and 
paternal functioning and the effect on maternal-infant interaction. Factors such as the type 
of delivery, the type of infant feeding, return-to-work time and infant temperament may be 
important, along with the degree of support from the father or other family members. A 
recent randomised trial set out to investigate if modification to the bedroom environment 
could improve the sleep of new parents (Lee & Gay, 2011). They evaluated a modified sleep 
hygiene intervention for new parents (infant proximity, noise masking, and dim lighting) in 
anticipation of night-time infant care in two samples of new mothers of different 
socioeconomic status. They were randomized to the experimental intervention or attention 
control, and sleep was assessed in late pregnancy and first 3 months postpartum using 
actigraphy and the General Sleep Disturbance Scale. The investigators observed that whilst 
the sleep hygiene strategies evaluated did not benefit the more socioeconomically 
advantaged women or their partners they did improve postpartum sleep among the less 
advantaged women suggesting that simple inexpensive changes to the bedroom 
environment can improve sleep for new mothers. 
Further studies are required fully to investigate the effects of smoking on sleep and 
associated adverse pregnancy outcomes but meanwhile educational programmes could be 
used to educate women on the possible harmful effects. Research to determine if other 
health behaviours could have beneficial effects on sleep in pregnant women is also required. 
For example, physical activity is recommended to pregnant women for health benefits but 
as yet there are insufficient studies to determine if this has any effect on improving sleep 
duration or quality. 
3. Conclusion  
A lack of sleep is known to affect both our physical and mental health. The few studies that 
have investigated sleep in pregnancy have found both an increase in total sleep time and an 
increase in daytime sleepiness in the first trimester whereas the third trimester appears to be 
associated with a decrease in sleep time and an increase in the number of awakenings. Sleep 
has an important impact on maternal and foetal health. It has been associated with an 
increased duration and pain perception in labour, with a higher rate of caesarean delivery 
and with preterm labour. Some pregnant women develop sleep disorders such as RLS or 
OSA or insomnia and others develop postpartum depression. Longitudinal studies are 
required to fully evaluate the effect of sleep deprivation on maternal and foetal outcome. 
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Better methods to measure sleep disturbances in pregnancy are required along with 
evaluation of the underlying cause so that appropriate and effect treatment can be 
administered. Particular attention needs to be given to women who develop leg complaints, 
who are overweight or become obese during pregnancy or develop conditions such as 
diabetes or PIH.  
4. Acknowledgment  
This work was in part funded by a University of Warwick Undergraduate Student 
Scholarship for Manisha Ahuja. We would like to thank Ms P McCabe for help in the 
preparation of the manuscript.  
5. References  
Akerstedt, T. & Nilsson, P. M. (2003). Sleep as restitution: an introduction. J Intern Med, 
Vol.254, No.1, pp. 6-12 
Arias, F.; Rodriquez, L.; Rayne, SC.; Kraus, FT. (1993). Maternal placental vasculopathy and 
infection: two distinct subgroups among patients with preterm labor and preterm 
ruptured membranes. Am J Obstet Gynecol, Vol.168, pp. 585–591 
Ategbo, J.M.; Grissa, O.; Yessoufou, A., Hichami, A,; Dramane, KL,; Moutairou, K,; Miled, 
A,; Grissa, A,; Jerbi, M,; Tabka, Z,; Khan, NA. (2006). Modulation of adipokines and 
cytokines in gestational diabetes and macrosomia. J Clin Endocrinol Metab, Vol.91, 
pp. 4137–4143 
Bachour, A.; Teramo, K.; Hiilesmaa, V. & Maasilta, P. (2008). Increased plasma levels of 
inflammatory markers and upper airway resistance during sleep in pre-eclampsia. 
Sleep medicine, Vol.9, No.6, pp. 667-674  
Baker, F.C.; Maloney, S. & Driver, H.S. (1999). A comparison of subjective estimates of sleep 
with objective polysomnographic data in healthy men and women. J Psychosom 
Res, Vol.47, No.4, pp. 335-341 
Bartha, J.L.; Romero-Carmona, R. & Comino-Delgado, R. (2003). Inflammatory cytokines in 
intrauterine growth retardation. Acta Obstet Gynecol Scand, Vol.82, pp. 1099–1102 
Benedict, C.; Scheller, J.; Rose-John, S.; Norn, J. & Marshall, L. (2009). Enhancing influence of 
intranasal interleukin-6 on slow-wave activity and memory consolidation during 
sleep. FASEB J, Vol.23, pp. 3629-3636 
Bernardi, F.; Guolo, F.; Bortolin, T.; Petronilho, F. & Dal-Pizzol, F. (2008). Oxidative stress 
and inflammatory markers in normal pregnancy and preeclampsia. J Obstet 
Gynaecol Res, Vol.34, No.6, pp. 948-51 
Bliwise, D. L. (1996). Historical change in the report of daytime fatigue. Sleep, Vol.19,,No.6, 
pp. 462-464  
Bourjeily, G (Ed). & Rosene-Montella, K (Ed). (2009). Pulmonary Problems in Pregnancy. 
Pub Springer Verlag Gmbh  
Cappuccio, F. P.; D'Elia, L.; Strazzullo, P. & Miller, M. A. (2010a). Quantity and quality of 
sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. 
Diabetes Care, Vol.33, No.2, pp. 414-420.  
Cappuccio, F. P.; D'Elia, L.; Strazzullo, P. & Miller, M. A. (2010b). Sleep duration and all-
cause mortality: a systematic review and meta-analysis of prospective studies. 
Sleep Vol.33, No.5, pp. 585-592.  
www.intechopen.com
Sleep and Pregnancy: Sleep Deprivation, 
Sleep Disturbed Breathing and Sleep Disorders in Pregnancy 
 
15 
Cappuccio, F. P.; Stranges, S.; Kandala, N.-B.; Miller, M. A.; Taggart, F. M.; Kumari, M.; 
Ferrie, J. E.; Shipley, M. J.; Brunner, E. J., & Marmot, G. (2007). Gender-Specific 
Associations of Short Sleep Duration with Prevalent and Incident Hypertension. 
The Whitehall II Study. Hypertension, Vol.50, No.4, pp. 694-701  
Cappuccio, F. P., Taggart, F. M., Kandala, N.-B., Currie, A., Peile, E., Stranges, S., & Miller, 
M. A. (2008). Meta-analysis of short sleep duration and obesity in children, 
adolescents and adults. Sleep, Vol.31, No.5, pp. 619-626  
Cappuccio, F.P. & Miller, M.A. (2011a). Is prolonged lack of sleep associated with obesity? 
BMJ, Vol. 26, pp. 342:d3306. doi: 10.1136/bmj.d3306.  
Cappuccio, F.P.; Cooper, D.; D'Elia, L.; Strazzullo, P. & Miller, M.A. (2011b). Sleep duration 
predicts cardiovascular outcomes: a systematic review and meta-analysis of 
prospective studies. Eur Heart J,Vol.32, No.12, pp.1484-1492. 
Carbonne B., Benachi A., Leveque M.L., Cabrol D., Papiemik E. (1996). Maternal position 
during labor: effect on fetal oxygen saturation measured by pulse oximetry. Obstet 
Gynecol, Vol.88, pp. 797-800. 
Champagne, K.A.; Kimoff, R.J.; Barriga, P.C. & Schwartzman, K. (2010). Sleep disordered 
breathing in women of childbearing age & during pregnancy. Indian J Med Res, 
Vol.131, pp. 285-301 
Chang, J.J.; Pien, G.W.; Duntley, S.P. & Macones, G.A. (2010). Sleep deprivation during 
pregnancy and maternal and fetal outcomes: is there a relationship? Sleep Med 
Rev, Vol.14, No.2, pp. 107-14. 
Chappel L.C., Smith G.C.S. (2011). Should pregnant women sleep on their left? BMJ, Vol.342, 
pp. d3649. 
Dayan, J.; Creveuil, C.; Marks, M.N.; Conroy, S.; Herlicoviez, M.; Dreyfus, M. & Tordjman, 
S. (2006). Prenatal depression, prenatal anxiety, and spontaneous preterm birth: A 
prospective cohort study among women with early and regular care. Psychosom 
Med, Vol.68, pp. 938-946 
Evans, M.L.; Dick, M.J. & Clark, A.S. (1995). Sleep during the week before labor: 
relationships to labor outcomes. Clin Nurs Res.,Vol.4, No.3, pp. 238-249 
Facco, F.L.; Kramer, J.; Ho, K.H.; Zee, P.C. & Grobman, W.A. (2010). Sleep disturbances in 
pregnancy. Obstet Gynecol. Vol.115, No.1, pp. 77-83 
Ferrie, J. E.; Shipley, M. J.; Cappuccio, F. P.; Brunner, E.; Miller, M. A.; Kumari, M. & 
Marmot, M. G. (2007). A prospective study of change in sleep duration: associations 
with mortality in the Whitehall II cohort. Sleep, Vol.30, No.12, pp. 1659-1666  
Fluhr, H.; Krenzer, S.; Stein, G.M., et al. (2007). Interferon-gamma and tumor necrosis factor-
alpha sensitize primarily resistant human endometrial stromal cells to Fas-
mediated apoptosis. J Cell Sci,Vol.120, pp. 4126–4133 
Freeman, D.J.; McManus, F.; Brown, E.A., et al. (2004). Short and long-term changes in 
plasma inflammatory markers associated with preeclampsia. Hypertension, Vol.44, 
pp. 708–714 
Gavin, N.I.; Gaynes, B.N.; Lohr, K.N.; Meltzer-Brody, S.; Gartlehner, G. & Swinson, T. (2005). 
Perinatal depression: a systematic review of prevalence and incidence. Obstet 
Gynecol, Vol.106, No.5 Pt 1, pp. 1071-1083.  
Goel, N.; Kim, H. & Lao, R.P. (2005). Gender differences in polysomnographic sleep in 
young healthy sleepers. Chronobiol Int, Vol.22, No.5, pp. 905-915 
www.intechopen.com
 
Sleep Disorders 
 
16
Groër, M.W. & Morgan, K. (2007). Immune, health and endocrine characteristics of 
depressed postpartum mothers. Psychoneuroendocrinology,  Vol.32, No.2pp.133-9. 
Guggisberg, A.G.; Hess, C.W. & Mathis, J. (2007). The significance of the sympathetic 
nervous system in the pathophysiology of periodic leg movements in sleep. Sleep, 
Vol.30, No.6, pp. 755-766 
Holcberg, G.; Huleihel, M.; Sapir, O., et al. (2001). Increased production of tumor necrosis 
factor-alpha TNF-alpha by IUGR human placentae. Eur J Obstet Gynecol Reprod 
Biol,Vol.94, pp. 69–72 
Izci, B.; Riha, R.L.; Martin, S.E.; Vennelle, M.; Liston, W.A.; Dundas, K.C.; Calder, A.A. & 
Douglas, N.J. (2003). The upper airway in pregnancy and pre-eclampsia. Am J 
Respir Crit Care Med,  Vol.167, No.2, pp. 137-140.  
Izci-Balserak, B. & Pien, G.W. (2010). Sleep-disordered breathing and pregnancy: potential 
mechanisms and evidence for maternal and fetal morbidity. Curr Opin Pulm Med,. 
Vol.16, No.6, pp. 574-582 
Izci-Balserak, B. (2008). Sleep-disordered breathing in pregnancy. Int J Sleep Wakefulness, 
Vol.1, pp. 98–108. 
Jeffreys R.M., Stepanchak W., Lopez B., Hardis J., Clapp J.F. 3rd (2006). Uterine blood flow 
during supine rest and exercise after 28 weeks of gestation. Br J Obstet Gynaecol, 
Vol.113, pp 1239-1247. 
Jerath, R.; Barnes, V.A. & Fadel, H.E. (2009). Mechanism of development of preeclampsia 
linking breathing disorders to endothelial dysfunction. Med Hypotheses, Vol.73, 
pp. 163–166. 
Khatib N., Haberman S., Belooseki R., Vitner D., Weiner Z., Thaler I. (2011) Maternal supine 
recumbency leads to brain auto-regulation in the fetus and elicits the brain sparing 
effect in low risk pregnancies. Am J Obstet Gynecol, Vol.204, pp. s278. 
Knutson, K. L.; Spiegel, K.; Penev, P. & Van Cauter, E. (2007). The metabolic consequences of 
sleep deprivation. Sleep Med Rev, Vol.11, No.3, pp. 163-178  
Knutsson, A. (2003). Health disorders of shift workers. Occup Med (Lond), Vol.53, No.2, pp. 
103-108. 
Köken, G.; Sahin, F. K.; Cosar, E.; Saylan, F.; Yilmaz, N.; Altuntas, I.; Fidan, F.; Unlu, M. & 
Yilmazer, M. (2007). Oxidative stress markers in pregnant women who snore and 
fetal outcome: a case control study. Acta Obstetricia et Gynecologica Scandinavica, 
Vol.86, No.11, pp. 1317-1321 
Ko, S.H.; Chang, S.C. & Chen, C.H. (2010). A comparative study of sleep quality between 
pregnant and nonpregnant Taiwanese women. J Nurs Scholarsh, Vol.42, No.1, pp. 
23-30.  
Labyak, S.; Lava, S.; Turek, F. & Zee, P. (2002). Effects of shiftwork on sleep and menstrual 
function in nurses. Health Care Women Int., Vol.23, No.6-7, pp. 703-714 
Lain, K.Y. & Catalano, P.M. (2007). Metabolic changes in pregnancy. Clin Obstet Gynecol, 
Vol.50, pp. 938–948 
Lindberg, E.; Janson, C.; Gislason, T.; Björnsson, E.; Hetta, J. & Boman, G. (1997). Sleep 
disturbances in a young adult population: can gender differences be explained by 
differences in psychological status? Sleep, Vol.20, No.6, pp. 381-387 
Lee, K.A. & Gay, C.L. (2004). Sleep in late pregnancy predicts length of labor and type of 
delivery. Am J Obstet Gynecol, Vol.191, No.6, pp. 2041-2046. 
www.intechopen.com
Sleep and Pregnancy: Sleep Deprivation, 
Sleep Disturbed Breathing and Sleep Disorders in Pregnancy 
 
17 
Lee, K.A. (1998). Alterations in sleep during pregnancy and postpartum: a review of 30 
years of research. Sleep Med Rev, Vol.2, No.4, pp. 231-242 
Lee, K.A. & Gay, C.L. (2011). Can modifications to the bedroom environment improve the 
sleep of new parents? Two randomized controlled trials. Res Nurs Health,  Vol.34, 
No.1, pp. 7-19. doi: 10.1002/nur.20413.  
Lee, K.A.; Zaffke, M.E. & Baratte-Beebe, K. (2001). Restless legs syndrome and sleep 
disturbance during pregnancy: the role of folate and iron. J Womens Health Gend 
Based Med, Vol.10, No.4, pp. 335-341 
Leung, P.L.; Hui, D.S.; Leung, T.N, Yuen, PM,; Lau, TK. (2005). Sleep disturbances in 
Chinese pregnant women. BJOG, Vol.112, pp. 1568–1571 
Lopes, E.A.; Carvalho, L.B.; Seguro, P.B.; Mattar, R.; Silva, A.B.; Prado, L.B. & Prado, G.F. 
(2004). Sleep disorders in pregnancy. Arq Neuropsiquiatr. June, Vol.62, No.2A, 
pp. 217-221.  
Maes, M.; Lin, A-H.; Ombelet, W.; Stevens, K.; Kenis, G.; deJongh, R.; Cox, J. & Bosmans, E 
(2000). Immune activation in the early puerperium is related to postpartum anxiety 
and depression symptoms. Psychoneuroendocrinology, Vol.5, pp. 121-137 
Makino, S.; Handa, H.; Suzukawa, K.; Fujiwara, M.; Nakamura, M.; Muraoka, S.; Takasago, 
I.; Tanaka, Y.; Hashimoto, K.; Sugimoto, T. (2006). Obstructive sleep apnoea 
syndrome, plasma adiponectin levels, and insulin resistance. Clin Endocrinol (Oxf), 
Vol.64, pp. 12–19. 
Manconi, M.; Govoni, V. ; De Vito, A.; Economou, N.T.; Cesnik, E.; Mollica, G. & Granieri, E. 
(2004). Pregnancy as a risk factor for restless legs syndrome. Sleep Med, Vol.5, 
No.3, pp. 305-308. Review 
Meerlo, P.; Sgoifo, A. & Suchecki, D. (2008). Restricted and disrupted sleep: effects on 
autonomic function, neuroendocrine stress systems and stress responsivity. Sleep 
Med Rev, Vol.12, pp. 197–210 
Miller, M. A. & Cappuccio, F. P. (2007). Inflammation, sleep, obesity and cardiovascular 
disease. Current Vascular Pharmacology, Vol.5, pp. 93-102 
Miller, M. A.; Kandala, N.-B.; Kivimaki, M.; Kumari, M.; Brunner, E. J.; Lowe, G. D. O.; 
Marmot, M. G. & Cappuccio, F. P. (2009). Gender differences in the cross-sectional 
relationships between sleep duration and markers of inflammation: Whitehall II 
study. Sleep, Vol.32, No.7, pp. 857-864  
Miller, G.E.; Rohleder, N.; Stetler, C. & Kirschbaum, C. (2005). Clinical depression and 
regulation of the inflammatory response during acute stress. Psychosom Med, 
Vol.67, pp. 679-687. 
Milsom I. & Forssman L. (1984) Factor influencing aortocaval compression in late 
pregnancy. Am J Obstet Gynecol, Vol.148,pp 764-771. 
Mohamed-Ali, V.; Goodrick, S.; Rawesh, A., Katz, DR.; Miles, JM.; Yudkin, JS.; Klein, S.; 
Coppack, SW. (1997). Subcutaneous adipose tissue releases interleukin-6, but not 
tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab., Vol.82, pp. 4196–
4200 
Naud, K.; Ouellet, A.; Brown, C.; Pasquier, J.C. & Moutquin, J.M. (2010). Is sleep disturbed 
in pregnancy? J Obstet Gynaecol Can, Vol.32, No.1, pp. 28-34 
Ohida, T.; Kaneita, Y.; Osaki, Y.; Harano, S.; Tanihata, T.; Takemura, S.; Wada, K.; Kanda, 
H.; Hayashi, K. & Uchiyama, M. (2007). Is passive smoking associated with sleep 
disturbance among pregnant women? Sleep, Vol.30, No.9, pp. 1155-1161 
www.intechopen.com
 
Sleep Disorders 
 
18
Okun, M.L.; Roberts, J.M.; Marsland, A.L. & Hall, M. (2009). How disturbed sleep may be a 
risk factor for adverse pregnancy outcomes. Obstet Gynecol Surv, Vol.64, No.4, pp. 
273-280  
Okun, M.L.; Hall, M. & Coussons-Read, M.E. (2007a). Sleep Disturbances Increase 
Interleukin-6 Production During Pregnancy: Implications for Pregnancy 
Complications. Reproductive Sciences, Vol.14, pp. 560-567 
Okun, M. L. & Coussons-Read, M.E. (2007b). Sleep disruption during pregnancy: How does 
it influence serum cytokines?  Journal of reproductive immunology, Vol.73, No. 2, 
pp. 158-165 
Okun, M.L.; Luther, J.; Prather, A.A.; Perel, J.M.; Wisniewski, S. & Wisner, K.L. (2011). 
Changes in sleep quality, but not hormones predict time to postpartum depression 
recurrence. J Affect Disord. Vol.130, No.3, pp. 378-384.  
Okun, M.L.;  Dunkel Schetter, C. & Glynn, L.M. (2011). Poor Sleep Quality is Associated 
with Preterm Birth. Sleep, (in press). 
Okun, M.L. 2011)  Biological consequences of disturbed sleep:Important mediators of 
health? Japanese Psychological Research, Vol 53, No. 2, pp 163–176 
Patel. V. & Prince, M. (2006). Maternal psychological morbidity and low birth weight in 
India. Brit J Psychiatry, Vol.188, pp. 284-285 
Pien, G.W. & Schwab, R.J. (2004). Sleep disorders during pregnancy. Sleep; 27:1405–1417 
Pires, G.N.; Andersen, M.L.; Giovenardi, M. & Tufik, S. (2010). Sleep impairment during 
pregnancy: possible implications on mother-infant relationship. Med Hypotheses, 
Vol.75, No.6, pp. 578-582.  
Punjabi, N.M.; Shahar, E.; Redline, S., et al. (2004). Sleep-disordered breathing, glucose 
intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol, 
Vol.160, pp. 521–530 
Qiu, C.; Sorensen, T.K.; Luthy, D.A. & Williams, M.A. (2004). A prospective study of 
maternal serum C-reactive protein (CRP) concentrations and risk of gestational 
diabetes mellitus. Paediatr Perinat Epidemiol, Vol.18, pp. 377–384 
Qiu. C.; Enquobahrie, D.; Frederick, I.O.; Abetew, D. & Williams, M.A. (2010). Glucose 
intolerance and gestational diabetes risk in relation to sleep duration and snoring 
during pregnancy: a pilot study. BMC Womens Health, Ma. Vol.10, p. 17  
Reid, J., Skomro, R.; Cotton, D.; Ward,H.; Olatunbosun, F.; Gjevre, J.; Christian G, MD, 
(2011). Pregnant women with gestational hypertension may have a high frequency 
of sleep disordered breathing, Sleep  in press 
Roberts, J.M. & Hubel, C.A. (2004). Oxidative stress in preeclampsia. Am J Obstet Gynecol; 
Vol.190, pp. 1177–1178 
Romero, R.; Espinoza, J.; Goncalves, L.F., et al. (2006). Inflammation in preterm and term 
labour and delivery. Seminin Fetal Neonatal Med.;Vol.11, pp. 317–326 
Salamonsen, L.A.; Hannan, N.J. & Dimitriadis, E. (2007). Cytokines and chemokines during 
human embryo implantation: roles in implantation and early placentation. Seminin 
Reprod Med,Vol.25, pp. 437–444 
Sapolsky, R.M.; Romero, L.M. & Munck, A.U. (2000). How do glucocorticoids influence 
stress responses? Integrating permissive, suppressive, stimulatory, and preparative 
actions. Endocr Rev, FVol.21, No.1, pp. 55-89.  
www.intechopen.com
Sleep and Pregnancy: Sleep Deprivation, 
Sleep Disturbed Breathing and Sleep Disorders in Pregnancy 
 
19 
Schlünssen, V.; Viskum, S.; Omland, Ø. & Bonde, J.P. (2007). [Does shift work cause 
spontaneous abortion, preterm birth or low birth weight?]. Ugeskr Laeger, Vol.169, 
No.10, pp. 893-900 
Sharma, A.; Satyam, A. & Sharma, J.B. (2007). Leptin IL-10 and inflammatory markers (TNF-
alpha, IL-6 and IL-8) in pre-eclamptic, normotensive pregnant and healthy non-
pregnant women. Am J Reprod Immunol, Vol.58, pp. 21–30  
Signal, T.L.; Gander, P.H.; Sangalli, M.R.; Travier, N.; Firestone, R.T.; Tuohy, J.F. (2007). 
Sleep duration and quality in healthy nulliparous and multiparous women across 
pregnancy and post-partum. Aust N Z J Obstet Gynaecol, Vol.47, No.1, pp. 16-22 
Spiegel, K.; Leproult, R. & Van Cauter, E. (1999). Impact of sleep debt on metabolic and 
endocrine function. Lancet, Vol.354, No.9188, pp. 1435-1439  
Spiegel, K.; Tasali, E.; Leproult, R. & Van Cauter, C. E. (2009). Effects of poor and short sleep 
on glucose metabolism and obesity risk. Nat.Rev.Endocrinol, Vol.5, No.5, pp. 253-
261. 
Stacey T., Thompson J.M.D., Mitchell E.A., Ekeroma A.J., Zuccollo J.M., McCowan L.M.E. 
(2011). Association between maternal sleep practices and risk of late stillbirth: a 
case-control study. BMJ, Vol.342, pp d3403. 
Stranges, S.; Dorn, J. M.; Shipley, M. J.; Kandala, N. B.; Trevisan, M.; Miller, M. A.; Donahue, 
R. P.; Hovey, K. M.; Ferrie, J. E.; Marmot, M.G. & Cappuccio, F. P. (2008). Correlates 
of short and long sleep duration: a cross-cultural comparison between the United 
Kingdom and the United States: the Whitehall II Study and the Western New York 
Health Study. Am.J.Epidemiol, Vol.168, No.12, pp. 1353-1364  
Stranges. S.; Dorn, J.M.; Cappuccio, F.P.; Donahue, R.P.; Rafalson, L.B.; Hovey, K.M.; 
Freudenheim, J.L.; Kandala, NB.; Miller, M.A. & Trevisan, M. (2010). A population-
based study of reduced sleep duration and hypertension: the strongest association 
may be in premenopausal women. J Hypertens, Vol.28, No.5, pp. 896-902 
Taheri, S.; Lin, L.; Austin, D.; Young, T. & Mignot, E. (2004). Short sleep duration is 
associated with reduced leptin, elevated ghrelin, and increased body mass index. 
PLoS.Med, Vol.1, No.3, p. e62 
Tauman, R.; Many, A.; Deutsch, V.; Arvas, S.; Ascher-Landsberg, J.; Greenfeld, M. & Sivan, 
Y. (2011). Maternal snoring during pregnancy is associated with enhanced fetal 
erythropoiesis - a preliminary study. Sleep Med, May, Vol.12, No.5, pp. 518-522 
Williams, M.A.; Qiu, C.; Muy-Rivera, M.; Vadachkoria, S.; Song, T.; Luthy, DA. (2004). 
Plasma adiponectin concentrations in early pregnancy and subsequent risk of 
gestational diabetes mellitus. J Clin Endocrinol Metab, Vol.89, pp. 2306–2311 
Wilson, D.L.; Barnes, M.; Ellett, L.; Permezel, M.; Jackson, M. & Crowe, S.F. (2010). 
Decreased sleep efficiency, increased wake after sleep onset and increased cortical 
arousals in late pregnancy. Aust N Z J Obstet Gynaecol, Vol.51, No1, pp.38-46.  
Wisner, K.L.; Chambers, C. & Sit, D.K. (2006). Postpartum depression: a major public health 
problem. JAMA. December 6, Vol.296, No.21, pp. 2616-2618 
Wolf, M.; Sauk, J.; Shah, A.; Vossen Smirnakis, K’; Jimenez-Kimble, R.; Ecker, JL.; Thadhani, 
R. (2004). Inflammation and glucose intolerance: a prospective study of gestational 
diabetes mellitus. Diabetes Care, Vol.27, pp.21–27 
Wolf, M.; Sandler, L.; Hsu, K.; Vossen-Smirnakis, K.; Ecker, JL.; Thadhani, R. (2003). First-
trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care, 
Vol.26, pp. 819–824 
www.intechopen.com
 
Sleep Disorders 
 
20
Wolfson, R.; Lee, KA (2005). Pregnancy and the Postpartum Period. In: The Principles and 
Practice of Sleep Medicine. Kryger, MH (Ed), Roth, T (Ed) & Dement, WC (Ed). 
pp.1278-1286. Elsevier. 
Zusterzeel, P.L.; Rütten, H.; Roelofs, H.M.; Peters, W.H. & Steegers, E.A. (2001). Protein 
carbonyls in decidua and placenta of pre-eclamptic women as markers for 
oxidative stress. Placenta, Vol.22, pp. 213–219 
www.intechopen.com
Sleep Disorders
Edited by Dr. Chris Idzikowski
ISBN 978-953-51-0293-9
Hard cover, 190 pages
Publisher InTech
Published online 14, March, 2012
Published in print edition March, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
For progress to be maintained in a clinical field like sleep medicine, unimpeded, unrestricted access to data
and the advances in clinical practice should be available. The reason why this book is exciting is that it breaks
down the barriers to dissemination of information, providing scientists, physicians, researchers and interested
individuals with a valuable insight into the latest diverse developments within the study of sleep disorders. This
book is a collection of chapters, which can be viewed as independent units dealing with different aspects and
issues connected to sleep disorders, having in common that they reflect leading edge ideas, reflections and
observations. The authors take into account the medical and social aspects of sleep-related disorders,
concentrating on different focus groups, from adults to pregnant women, adolescents, children and
professional workers.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Michelle A. Miller, Manisha Ahuja and Francesco P. Cappuccio (2012). Sleep and Pregnancy: Sleep
Deprivation, Sleep Disturbed Breathing and Sleep Disorders in Pregnancy, Sleep Disorders, Dr. Chris
Idzikowski (Ed.), ISBN: 978-953-51-0293-9, InTech, Available from: http://www.intechopen.com/books/sleep-
disorders/sleep-and-pregnancy-sleep-deprivation-sleep-disturbed-breathing-and-sleep-disorders-in-pregnancy
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
